Discovering Moderna’s new landscape for vaccines in Europe

This week, EURACTIV’s health team talks with Chantal Friebertshäuser, Senior Vice President at Moderna for Europe, the Middle East, Canada and Australia. They discuss the end of COVID and the new vaccine they are developing against cancer. 

They also talk about the new facility the biotechnology company recently opened in Madrid, Spain. This new laboratory, equipped with the latest technology, is the biggest end-to-end production hub for Moderna outside the United States.